| 产品名称 | 产品编号 | CAS编号 | 分子式 = 分子量 | 位单 | 联系QQ |
| 苦绳甙Aa1; Dregeoside Aa1 | CFN97790 | 20230-41-5 | C49H78O17 = 939.15 | 5mg | QQ客服：3257982914 |
| 通关藤苷I; Tenacissoside I | CFN97794 | 191729-44-9 | C44H62O14 = 814.97 | 20mg | QQ客服：1457312923 |
| 通关藤苷G; Tenacissoside G | CFN97795 | 191729-43-8 | C42H64O14 = 792.96 | 20mg | QQ客服：215959384 |
| Dehydroadynerigenin beta-neritrioside; Dehydroadynerigenin beta-neritrioside | CFN97820 | 143212-60-6 | C42H62O17 = 838.95 | 5mg | QQ客服：3257982914 |
| 通关藤苷H; Tenacissoside H | CFN90428 | 191729-45-0 | C42H66O14 = 794.97 | 20mg | QQ客服：3257982914 |
| 薯蓣次苷A; Prosapogenin A | CFN90440 | 19057-67-1 | C39H62O12 = 722.9 | 10mg | QQ客服：3257982914 |
| 重楼皂苷C; Polyphyllin C | CFN90445 | 76296-71-4 | C39H62O12 = 722.9 | 5mg | QQ客服：2056216494 |
| 重楼皂苷E; Polyphyllin E | CFN90446 | 76296-73-6 | C51H82O20 = 1015.18 | 5mg | QQ客服：2056216494 |
| 重楼皂苷F; Polyphyllin F | CFN90447 | 76296-74-7 | C51H82O20 = 1015.18 | 5mg | QQ客服：2056216494 |
| 强心苷B-1; Cardenolide B-1 | CFN97830 | 1318158-89-2 | C30H44O8 = 532.68 | 5mg | QQ客服：1457312923 |
| (14beta,22E)-8,14-环氧基麦角甾-4,22-二烯-3,6-二酮; 8,14-Epoxyergosta-4,22-diene-3,6-dione | CFN97834 | 1265908-20-0 | C28H40O3 = 424.62 | 5mg | QQ客服：1413575084 |
| 苦绳苷元A; Drevogenin A | CFN97862 | 10163-83-4 | C28H42O7 = 490.64 | 5mg | QQ客服：1457312923 |
| 菜籽甾醇; Brassicasterol | CFN90471 | 474-67-9 | C28H46O = 398.66 | 5mg | QQ客服：1413575084 |
| 鹅去氧胆酸； 鹅脱氧胆酸; Chenodeoxycholic acid | CFN90478 | 474-25-9 | C24H40O4 = 392.57 | 20mg | QQ客服：1413575084 |
| 蜕皮激素; Ecdysone | CFN90487 | 3604-87-3 | C27H44O6 = 464.63 | 5mg | QQ客服：3257982914 |
Cell. 2018 Jan 11;172(1-2):249-261.e12. doi: 10.1016/j.cell.2017.12.019.IF=36.216(2019)
Cell Metab. 2020 Mar 3;31(3):534-548.e5. doi: 10.1016/j.cmet.2020.01.002.IF=22.415(2019)
Mol Cell. 2017 Nov 16;68(4):673-685.e6. doi: 10.1016/j.molcel.2017.10.022.IF=14.548(2019)
ACS Nano. 2018 Apr 24;12(4): 3385-3396. doi: 10.1021/acsnano.7b08969.IF=13.903(2019)
Nature Plants. 2016 Dec 22;3: 16206. doi: 10.1038/nplants.2016.205.IF=13.297(2019)
Sci Adv. 2018 Oct 24;4(10): eaat6994. doi: 10.1126/sciadv.aat6994.IF=12.804(2019)